Posted By

Tags

FMA suspends AxiCorp derivatives licence

Supplied Content

The Financial Markets Authority (FMA) has suspended the derivatives issuer licence of AxiCorp Financial Services Pty Limited (trading as AxiTrader) for material breaches of the Financial Markets Conduct Act 2013.

The breaches include (a) making a regulated offer to retail clients in New Zealand without a compliant Product Disclosure Statement or Disclose register entry (b) failing to lodge audited financial statements and (c) failing to obtain an assurance engagement with a qualified auditor, for its processes, procedures and controls, within 4 months of its balance date.

Licence Conditions contravened

AxiCorp also contravened its licence conditions by failing to notify the FMA as soon as practicable of a change to senior or other key staff, following the appointment of its CFO.

The FMA considers that AxiCorp has demonstrated that it does not have adequate systems, processes, or resources in place to ensure compliance with the Financial Markets Conduct Act, or to effectively perform services under a licence.

AxiCorp’s licence will remain suspended until the FMA is satisfied that its concerns have been addressed.

The terms of the suspension ensure that the FMA has oversight of AxiCorp’s remediation efforts.

During the suspension, AxiCorp is permitted to act as a derivatives issuer in respect of a regulated offer of derivatives for the sole purpose of entering into derivatives with existing clients in order to close out any open position(s) AxiCorp has with existing clients.

The suspension is effective from July 29, 2019.

*

(Image from FMA Website)

Share this story

Related Stories

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Indian Newslink

Previous slide
Next slide

Advertisement

Previous slide
Next slide

Advertisement

Previous slide
Next slide

Advertisement

Previous slide
Next slide

Advertisement

Previous slide
Next slide

Advertisement

Advertisement

Previous slide
Next slide

Advertisement

Previous slide
Next slide

Advertisement

Previous slide
Next slide

Advertisement